1,177
Views
34
CrossRef citations to date
0
Altmetric
Article Addendum

Muco-cutaneous leishmaniasis in the New World

The ultimate subversion

Pages 547-552 | Received 08 Jul 2011, Accepted 23 Aug 2011, Published online: 01 Nov 2011

References

  • Ronet C, Ives A, Bourreau E, Fasel N, Launois P, Masina S. Jirillo E, Brandonisio O. Immune responses to Leishmania guyanensis infection in humans and animal models. Immune Response to Parasitic Infections: Protozoa 2010; Bussum Bentham eBooks 165 - 177
  • Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verastegui C, et al. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 2007; 195:1846 - 1851; PMID: 17492601; http://dx.doi.org/10.1086/518041
  • Souza AS, Giudice A, Pereira JM, Guimaraes LH, de Jesus AR, de Moura TR, et al. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNFalpha production. BMC Infect Dis 2010; 10:209; PMID: 20633260; http://dx.doi.org/10.1186/1471-2334-10-209
  • Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol 2009; 31:423 - 431; PMID: 19646206; http://dx.doi.org/10.1111/j.1365-3024.2009.01116.x
  • Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, et al. Upregulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70:6734 - 6740; PMID: 12438348; http://dx.doi.org/10.1128/IAI.70.12.6734-40.2002
  • Gomes-Silva A, de Cassia Bittar R, Dos Santos Nogueira R, Amato VS, da Silva Mattos M, Oliveira-Neto MP, et al. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?. Clin Exp Immunol 2007; 149:440 - 444; PMID: 17614975; http://dx.doi.org/10.1111/j.1365-2249.2007.03436.x
  • Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993; 91:1390 - 1395; PMID: 8473490; http://dx.doi.org/10.1172/JCI116341
  • Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005; 73:7853 - 7859; PMID: 16299275; http://dx.doi.org/10.1128/IAI.73.12.7853-9.2005
  • Gaze ST, Dutra WO, Lessa M, Lessa H, Guimaraes LH, Jesus AR, et al. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 2006; 63:70 - 78; PMID: 16398703; http://dx.doi.org/10.1111/j.1365-3083.2005.01707.x
  • Vargas-Inchaustegui DA, Hogg AE, Tulliano G, Llanos-Cuentas A, Arevalo J, Endsley JJ, et al. CXCL10 production by human monocytes in response to Leishmania braziliensis infection. Infect Immun 2010; 78:301 - 308; PMID: 19901067; http://dx.doi.org/10.1128/IAI.00959-09
  • Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001; 65:87 - 89; PMID: 11508396
  • Travi B, Rey-Ladino J, Saravia NG. Behavior of Leishmania braziliensis s.l. in golden hamsters: evolution of the infection under different experimental conditions. J Parasitol 1988; 74:1059 - 1062; PMID: 3193329; http://dx.doi.org/10.2307/3282237
  • Martinez JE, Travi BL, Valencia AZ, Saravia NG. Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters. J Parasitol 1991; 77:762 - 768; PMID: 1919926; http://dx.doi.org/10.2307/3282713
  • Martínez JE, Valderrama L, Gama V, Leiby DA, Saravia NG. Clonal diversity in the expression and stability of the metastatic capability of Leishmania guyanensis in the golden hamster. J Parasitol 2000; 86:792 - 799; PMID: 10958458
  • Travi BL, Osorio Y, Saravia NG. The inflammatory response promotes cutaneous metastasis in hamsters infected with Leishmania (Viannia) panamensis. J Parasitol 1996; 82:454 - 457; PMID: 8636852; http://dx.doi.org/10.2307/3284085
  • Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007; 39:839 - 847; PMID: 17572675; http://dx.doi.org/10.1038/ng2053
  • Lye LF, Owens K, Shi H, Murta SM, Vieira AC, Turco SJ, et al. Retention and loss of RNA interference pathways in Trypanosomatid protozoans. PLoS Pathog 2010; 6:1001161; PMID: 21060810; http://dx.doi.org/10.1371/journal.ppat.1001161
  • Tarr PI, Aline RF Jr, Smiley BL, Scholler J, Keithly J, Stuart K. LR1: a candidate RNA virus of Leishmania. Proc Natl Acad Sci USA 1988; 85:9572 - 9575; PMID: 3200841; http://dx.doi.org/10.1073/pnas.85.24.9572
  • Widmer G, Comeau AM, Furlong DB, Wirth DF, Patterson JL. Characterization of a RNA virus from the parasite Leishmania. Proc Natl Acad Sci USA 1989; 86:5979 - 5982; PMID: 2762308; http://dx.doi.org/10.1073/pnas.86.15.5979
  • Scheffter S, Widmer G, Patterson JL. Complete sequence of Leishmania RNA virus 1–4 and identification of conserved sequences. Virology 1994; 199:479 - 483; PMID: 8122377; http://dx.doi.org/10.1006/viro.1994.1149
  • Stuart KD, Weeks R, Guilbride L, Myler PJ. Molecular organization of Leishmania RNA virus 1. Proc Natl Acad Sci USA 1992; 89:8596 - 8600; PMID: 1382295; http://dx.doi.org/10.1073/pnas.89.18.8596
  • Cadd TL, Keenan MC, Patterson JL. Detection of Leishmania RNA virus 1 proteins. J Virol 1993; 67:5647 - 5650; PMID: 8350417
  • Saiz M, Llanos-Cuentas A, Echevarria J, Roncal N, Cruz M, Muniz MT, et al. Short report: detection of Leishmania virus in human biopsy samples of leishmaniasis from Peru. Am J Trop Med Hyg 1998; 58:192 - 194; PMID: 9502603
  • Ro YT, Scheffter SM, Patterson JL. Hygromycin B resistance mediates elimination of Leishmania virus from persistently infected parasites. J Virol 1997; 71:8991 - 8998; PMID: 9371555
  • Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NFkappaB by Toll-like receptor 3. Nature 2001; 413:732 - 738; PMID: 11607032; http://dx.doi.org/10.1038/35099560
  • Pindado J, Balsinde J, Balboa MA. TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway. J Immunol 2007; 179:4821 - 4828; PMID: 17878381
  • Ro YT, Scheffter SM, Patterson JL. Specific in vitro cleavage of a Leishmania virus capsid-RNA-dependent RNA polymerase polyprotein by a host cysteine-like protease. J Virol 1997; 71:8983 - 8990; PMID: 9371554
  • Zangger H, Mottram JC, Fasel N. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis?. Cell Death Differ 2002; 9:1126 - 1139; PMID: 12232801; http://dx.doi.org/10.1038/sj.cdd.4401071
  • Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, et al. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection?. Lancet 1990; 336:398 - 402; PMID: 1974943; http://dx.doi.org/10.1016/0140-6736(90)91945-7
  • Ogg MM, Carrion R Jr, Botelho AC, Mayrink W, Correa-Oliveira R, Patterson JL. Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis. Am J Trop Med Hyg 2003; 69:309 - 313; PMID: 14628949